XML 33 R31.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Equity method investment (Tables)

12 Months Ended

Dec. 31, 2019

Equity Method Investments and Joint Ventures [Abstract]

Equity Method Investments

The following summary of BHG's financial position and results of operations as of and for the years ended December 31, 2019 and 2018, respectively, are presented as unaudited due to BHG's fiscal year end being September 30 (unaudited, in thousands):

Banker's Healthcare Group
			December 31, 2019						December 31, 2018
Assets			$	840,398					$	459,816
Liabilities			$	641,037					$	324,211
Equity interests			199,361						135,605
Total liabilities and equity			$	840,398					$	459,816

			For the year ended December 31,
			2019						2018						2017
Revenues			$	366,500					$	220,253					$	160,209
Net income, pre-tax			$	182,462					$	104,297					$	77,941

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

+ Details

Name:	us-gaap_EquityMethodInvestmentsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration